Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Neoplasms 4Lymphedema 2Depression 2Colorectal Neoplasms 2Breast Neoplasms 2Anxiety Disorders 2Unspecified Adult Solid Tumor, Protocol Specific 1Stress Disorders, Post-Traumatic 1Sedentary Behavior 1Rectal Neoplasms 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Pain 1Overweight 1Obesity 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Head and Neck Neoplasms 1Fatigue 1Digestive System Neoplasms 1Colonic Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 51Ipilimumab 49Cyclophosphamide 43Nivolumab 40aldesleukin 30Interleukin-2 23Vemurafenib 20fludarabine 19Temozolomide 18fludarabine phosphate 15dabrafenib 15trametinib 12Radiosurgery 10Dacarbazine 10CTLA-4 Antigen 10spartalizumab 9cobimetinib 9binimetinib 9Radiotherapy 9poly ICLC 7encorafenib 7Paclitaxel 7atezolizumab 6Introns 6Biopsy 6montanide ISA 51 5Carboplatin 5epacadostat 4MART-1 Antigen 4Interferon alpha-2 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Melanoma × Methods × Clear all
NCT05388851 2025-06-22

Education for Prevention of Melanoma in Hispanic Populations

Mayo Clinic

Phase 2 Terminated
145 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡